Aldeyra Therapeutics logo

Aldeyra Therapeutics

Aldehyde-trap therapies

4

Funding Rounds

$267.5m

Money raised

Overview

Aldehyde-trap therapies

Funding series

Funding Series Analysis

The company Aldeyra Therapeutics has raised a total of $7.8m in funding over 4 rounds.

Key Insights:

  • Aldeyra Therapeutics Post-IPO Equity, January 2015: $7.8m
  • Aldeyra Therapeutics Post-IPO Equity, April 2021: $125m
  • Aldeyra Therapeutics Post-IPO Equity, January 2021: $74.7m
  • Aldeyra Therapeutics Post-IPO Equity, March 2019: $60m
Aldeyra Therapeutics logo
Aldeyra Therapeutics Post-IPO Equity, January 2015 $7.8m
Aldeyra Therapeutics logo
Aldeyra Therapeutics Post-IPO Equity, March 2019 $60m
Aldeyra Therapeutics logo
Aldeyra Therapeutics Post-IPO Equity, January 2021 $74.7m
Aldeyra Therapeutics logo
Aldeyra Therapeutics Post-IPO Equity, April 2021 $125m

Industries

Aldeyra Therapeutics is active in the following industries:
  • Biomedical engineering
  • Technology
  • Biology
  • Biotechnology
  • Dry eye syndrome
  • Eye health technology
  • Engineering